Low Leachable Container System Consisting of a Polymer-Based Syringe with Chlorinated Isoprene Isobutene Rubber Plunger Stopper

References

1. 1.↵
   1. Singh S. K.,
   2. Afonina N.,
   3. Awwad M.,
   4. Bechtold-Peters K.,
   5. Blue J. T.,
   6. Chou D.,
   7. Cromwell M.,
   8. Krause H.J.,
   9. Mahler H. C.,
   10. Meyer B. K.,
   11. Narhi L.,
   12. Nesta D. P.,
   13. Spitznagel T.

   An industry prospective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. J. Pharm. Sci. 2010, 99(8), 3302–3321.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Ripple D. C.,
   2. Dimitrova M. N.

   Protein particles: what we know and what we do not know. J. Pharm. Sci. 2012, 101(10), 3568–3579.

   OpenUrlPubMed
3. 3.↵
   1. Bee J. S.,
   2. Goletz T. J.,
   3. Ragheb J. A.

   The future of protein characterization and understanding its potential to diminish the immunogenicity of biopharmaceuticals: a shared perspective. J. Pharm. Sci. 2011, 101(10), 3580–3585.

   OpenUrl
4. 4.↵
   1. Majumdar S.,
   2. Ford B. M.,
   3. Mar K. D.,
   4. Sullivan V. J.,
   5. Ulrich R. G.,
   6. D'souza A. J. M.

   Evaluation of the effect of syringe surfaces on protein formulations. J. Pharm. Sci. 2011, 100(7), 2563–2573.

   OpenUrlPubMed
5. 5.↵
   1. Yoshino K.,
   2. Nakamura T.,
   3. Yamashita A.,
   4. Abe Y.,
   5. Iwasaki K.,
   6. Kanazawa Y.,
   7. Funatsu K.,
   8. Yoshimoto T.,
   9. Suzuki S.

   Functional evaluation and characterization of a newly developed silicone oil–free prefillable syringe system. J. Pharm. Sci. 2014, 103(5), 1520–1528.

   OpenUrlPubMed
6. 6.↵
   1. Krayukhina E.,
   2. Tsumoto K.,
   3. Uchiyama S.,
   4. Fukui K.

   Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins. J. Pharm. Sci. 2015, 104(2), 527–535.

   OpenUrlPubMed
7. 7.↵
   1. Depaz A. R.,
   2. Chevolleau T.,
   3. Jouffeay S.,
   4. Narwal R.,
   5. Dimitrova M. N.

   Cross-linked silicone coating: novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics. J. Pharm. Sci. 2014, 103(5), 1384–1393.

   OpenUrlPubMed
8. 8.↵
   1. Nakamura K.,
   2. Abe Y.,
   3. Kiminami H.,
   4. Yamashita A.,
   5. Iwasaki K.,
   6. Suzuki S.,
   7. Yoshino K.,
   8. Dierick W.,
   9. Constable K.

   A strategy for the prevention of protein oxidation by drug product in polymer-based syringes. PDA J. Pharm. Sci, Technol. 2015, 69(1), 88–95.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Nakamura K.,
   2. Kiminami H.,
   3. Yamashita A.,
   4. Abe Y.,
   5. Yoshino K.,
   6. Suzuki S.

   Assessment of the effects of sterilization methods on protein drug stability by elucidating decomposition mechanism and material analysis. Int. J. Pharm. 2015, 484(1–2), 51–56.

   OpenUrlPubMed
10. 10.↵
    1. Jenke D.

    Extractable/Leachable Substances from Plastic Materials Used as Pharmaceutical Product Containers/Devices. PDA J. Pharm. Sci. Technol. 2002, 56(6), 332–371.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Jenke D.

    Linking Extractables aand Leachables in Container/Closure Applications. PDA J. Pharm. Sci. Technol. 2005, 59(4), 265–281.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Markovic I.

    Evaluation of safety and quality impact of extractable and leachable substances in therapeutic biologic protein products: a risk-based perspective. Expert Opin. Drug Saf 2007, 6(5), 487–491.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Basant S.

    Immunogenicity of therapeutic proteins. Part 2: Impact of container closure. Biotechnology Advances 2007, 25(3), 318–324.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Jenke D.,
    2. Zietlow D.,
    3. Garber M. J.,
    4. Sadain S.,
    5. Reiber D.,
    6. Terbush W.

    Accumulation of organic compounds leached from plastic materials used in biopharmaceutical process containers. PDA J. Pharm. Sci. Technol. 2007, 61(4), 286–302.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Wakankar A. A.,
    2. Wang Y. J.,
    3. Canova-Davis E.,
    4. Ma S.,
    5. Schmalzing D.,
    6. Grieco J.,
    7. Milby T.,
    8. Reynolds T.,
    9. Mazzarella K.,
    10. Hoff E.,
    11. Gomez S.,
    12. Martin-Moe S.

    On developing a process for conducting extractable-leachable assessment of components used for storage of biopharmaceuticals. J. Pharm. Sci. Technol. 2010, 99(5), 2209–2218.

    OpenUrl
16. 16.↵
    1. Jenke D.

    Extractable/leachable substances from plastic materials used as pharmaceutical product containers/devices. PDA J. Pharm. Sci. Technol. 2002, 56(6), 332–371.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Ding W.,
    2. Nash R.

    Extractables from integrated single-use systems in biopharmaceutical manufacturing. Part 1. Study on components (Pall Kleenpak connector and Kleenpak filter capsule). PDA J. Pharm. Sci. Technol. 2009, 63(4), 322–328.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Jenke D.,
    2. Odufu A.,
    3. Couch T.,
    4. Chacko M.,
    5. Strathmann S.,
    6. Edgcomb E.

    Evaluation of the general solution compatibility of polymer materials used in medical devices such as syringes. PDA J. Pharm. Sci. Technol. 2012, 66(4), 286–306.

    OpenUrlAbstract/FREE Full Text